C07D 211/28
To which a second hetero atom is attached
Official title: to which a second hetero atom is attached
C07D211/28 (To which a second hetero atom is attached) appears on 146 US grants and 147 published applications in this corpus.
Search patents in C07D- Granted patents
- 146
- Published applications
- 147
- Assignees
- 129
- Inventors
- 642
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 8 | 3 |
| 2003 | 3 | 7 |
| 2004 | 4 | 14 |
| 2005 | 8 | 11 |
| 2006 | 7 | 14 |
| 2007 | 4 | 4 |
| 2008 | 4 | 6 |
| 2009 | 6 | 5 |
| 2010 | 8 | 3 |
| 2011 | 2 | 3 |
| 2012 | 5 | 7 |
| 2013 | 5 | 6 |
| 2014 | 6 | 3 |
| 2015 | 2 | 7 |
| 2016 | 2 | 2 |
| 2017 | 1 | 8 |
| 2018 | 6 | 7 |
| 2019 | 5 | 5 |
| 2020 | 6 | 6 |
| 2021 | 2 | 5 |
| 2022 | 2 | 4 |
| 2023 | 1 | 13 |
| 2024 | 1 | 2 |
| 2025 | 4 | 1 |
| 2026 | 4 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for targeting Tregs using CCR8 inhibitors28 Jul 2026US 12,692,239 B2Nanjing Immunophage Biomedical Co., Ltd.
- Agents for differentiating stem cells and treating cancer19 May 2026US 12,630,512 B2Minerva Biotechnologies Corporation
- Pesticidally active cyclic amine compounds21 Apr 2026US 12,604,895 B2Syngenta Crop Protection AG
- Methods and compositions for targeting Tregs using CCR8 inhibitors17 Feb 2026US 12,552,753 B2Nanjing Immunophage Biomedical Co., Ltd.
- Small molecules for cancer therapy that reduce the expression of transcription factors KLF5 and EGR-12 Dec 2025US 12,486,227 B2The Research Foundation for The State University of New York
- Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators10 Sep 2026US 2026/0265190 A1Rappta Therapeutics Oy
- Heterocyclic compound7 Aug 2025US 2025/0250230 A1
- Agents for differentiating stem cells and treating cancer12 Dec 2024US 2024/0409515 A1Minerva Biotechnologies Corporation
- Substituted cyclic modulators of protein phosphatase 2a (pp2a) and methods using same30 May 2024US 2024/0174611 A1Rappta Therapeutics Oy
- N-((1-benzylpiperidin-3-yl)methyl)-n-(2-methoxyethyl)naphthalene-2-sulfonamide for the treatment of canine cognitive dysfunction and other forms of dementia in dogs19 Oct 2023US 2023/0331674 A1Univerza v Ljubljani
Most cited
By later US patents
- Cyclic amine compounds with activity against acetylcholinesterase174US 4,895,841 AEisai Co., Ltd. · 1990
- Cyclic amine compounds and pharmaceutical use91US 5,100,901 AEisai Co., Ltd. · 1992
- 3-(4-Piperidyl)-1,2-benzisoxales88US 4,355,037 AHoechst-Roussel Pharmaceuticals Inc. · 1982
- Aromatic amides of heterocyclic compounds and therapeutic compositions containing same68US 4,138,492 AAnphar, S.A. · 1979
- 4-phenylpiperidines for the treatment of pruritic dermatoses53US 6,610,711 B2Pfizer Inc. · 2003